Cutler Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-171
Closed -$7K 4723
2022
Q4
$7K Buy
+171
New +$7.74K ﹤0.01% 2978
2022
Q3
Sell
-6
Closed -$329 5520
2022
Q2
$0 Sell
6
-1,445
-100% -$119K ﹤0.01% 5675
2022
Q1
$168K Buy
+1,451
New +$169K 0.01% 1320
2021
Q3
Sell
-325
Closed -$35.8K 6353
2021
Q2
$31K Buy
+325
New +$29K ﹤0.01% 2913
2019
Q1
Sell
-100
Closed -$5.25K 4757
2018
Q4
$3K Sell
100
-2,684
-96% -$94.8K ﹤0.01% 3234
2018
Q3
$119K Buy
2,784
+1,284
+86% +$44.8K 0.01% 1101
2018
Q2
$33K Sell
1,500
-100
-6% -$1.23K ﹤0.01% 1865
2018
Q1
$7K Hold
1,600
﹤0.01% 3077
2017
Q4
$3K Hold
1,600
﹤0.01% 3996
2017
Q3
$11K Sell
1,600
-510
-24% -$3.23K ﹤0.01% 3738
2017
Q2
$16K Sell
2,110
-4,145
-66% -$38.3K ﹤0.01% 3664
2017
Q1
$75K Buy
6,255
+1,483
+31% +$32.4K ﹤0.01% 2022
2016
Q4
$102K Buy
4,772
+4,560
+2,151% +$175K ﹤0.01% 1890
2016
Q3
$16K Sell
212
-100
-32% -$7.29K ﹤0.01% 3669
2016
Q2
$23K Buy
312
+307
+6,140% +$24.7K ﹤0.01% 3217
2016
Q1
$0 Sell
5
-121
-96% -$10.6K ﹤0.01% 7204
2015
Q4
$14K Buy
+126
New +$12.5K ﹤0.01% 3790

Other funds holding TNDM

Cutler Group's TNDM Position: Q1 2023 in Review

Cutler Group sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 171 shares — an estimated $7K sold.

Cutler Group first reported a position in TNDM in Q4 2015 and held it in 17 quarters. The position peaked at $168K in Q1 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Cutler Group reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 171 Tandem Diabetes Care shares in Q1 2023, an estimated $7K.
  • Cutler Group first reported a position in Tandem Diabetes Care in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Tandem Diabetes Care position peaked at $168K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.